Arizona Neurological Emergencies Treatment Trials Network

亚利桑那州神经紧急情况治疗试验网络

基本信息

  • 批准号:
    8069145
  • 负责人:
  • 金额:
    $ 19.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-03 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Emergencies caused by acute neurological disorders and injuries are common and the health burden of these conditions to patients and society is well documented. The outcome of many neurological disorders is often determined within the first minutes after onset and intervention in the emergency department or even prior to emergency department arrival may be necessary to provide meaningful benefit. The optimal treatments for these conditions are not well described, in part because the clinical research in the United States has not conducted many intervention trials targeting the earliest phases of treatment. Another obstacle facing investigators is the ability to enroll a sufficient number of volunteers to obtain statistical significance in testing the intervention. To overcome these challenges, the National Institutes of Neurological Disease and Strokes (NINDS) endeavors to create a wide network of major and community hospitals, referred to as the "hub and spoke" model. This model seeks to capture a wide socio-demographic profile including minority and underserved individuals, while obviating protracted timelines implicit in clinical trials. NINDS has selected the Department of Emergency Medicine at the University of Michigan as the Clinical Coordinating Center, and a data coordinating site will be identified. Our team will contribute significantly to this network by incorporating three major hospitals from Arizona's two metropolitan areas and four rural hospitals. The hub and spoke design of the Arizona Neurological Emergencies Treatment Trials Network (AzNETT) will be enhanced by incorporating rural hospitals already included in the University of Arizona's Telemedicine Program. Through this growing infrastructure, we will be able to investigate the effectiveness of new therapies in a broader range of service environments, while striving to augment the quality of patient care. The key elements of this structure will include an interdisciplinary team of emergency physicians, neurologists, neurosurgeons, coordinators, program managers and information technologists with specific expertise in the conduct of emergent clinical trials. Team members in both the hub and spoke sites have demonstrated a long term commitment to advancing the national research infrastructure as it relates to the interdisciplinary study of emergent illness.
描述(由申请人提供):由急性神经系统疾病和损伤引起的紧急情况很常见,这些疾病给患者和社会带来的健康负担有据可查。许多神经系统疾病的结果通常在发病后的最初几分钟内确定,并且可能需要在急诊科甚至在到达急诊科之前进行干预才能提供有意义的益处。针对这些病症的最佳治疗方法尚未得到很好的描述,部分原因是美国的临床研究尚未针对早期治疗阶段进行许多干预试验。研究人员面临的另一个障碍是招募足够数量的志愿者以获得测试干预措施的统计显着性的能力。为了克服这些挑战,美国国家神经疾病和中风研究所 (NINDS) 努力创建一个由主要医院和社区医院组成的广泛网络,称为“中心辐射”模式。该模型旨在捕捉广泛的社会人口特征,包括少数族裔和服务不足的个人,同时避免临床试验中隐含的拖延时间。 NINDS 已选择密歇根大学急诊医学系作为临床协调中心,并将确定数据协调站点。我们的团队将合并亚利桑那州两个大都市区的三家主要医院和四家乡村医院,为该网络做出重大贡献。亚利桑那州神经紧急情况治疗试验网络(AzNETT)的中心和辐射设计将通过纳入亚利桑那大学远程医疗计划中已包含的乡村医院得到加强。通过不断发展的基础设施,我们将能够在更广泛的服务环境中研究新疗法的有效性,同时努力提高患者护理的质量。该结构的关键要素将包括一个由急诊科医生、神经科医生、神经外科医生、协调员、项目经理和信息技术人员组成的跨学科团队,他们在进行紧急临床试验方面具有特定的专业知识。中心和辐射站点的团队成员都表现出了对推进国家研究基础设施的长期承诺,因为这与突发疾病的跨学科研究有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KURT R DENNINGHOFF其他文献

KURT R DENNINGHOFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KURT R DENNINGHOFF', 18)}}的其他基金

1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
1/2:阿奇霉素治疗在急诊科诊断出严重喘息发作的学龄前儿童 (AZ-SWED)
  • 批准号:
    10274820
  • 财政年份:
    2020
  • 资助金额:
    $ 19.41万
  • 项目类别:
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
1/2:阿奇霉素治疗在急诊科诊断出严重喘息发作的学龄前儿童 (AZ-SWED)
  • 批准号:
    9893463
  • 财政年份:
    2020
  • 资助金额:
    $ 19.41万
  • 项目类别:
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
1/2:阿奇霉素治疗在急诊科诊断出严重喘息发作的学龄前儿童 (AZ-SWED)
  • 批准号:
    10525247
  • 财政年份:
    2020
  • 资助金额:
    $ 19.41万
  • 项目类别:
ED-Initiated School-based Asthma Medication Supervision (ED-SAMS)
教育署发起的校本哮喘药物监督 (ED-SAMS)
  • 批准号:
    9762155
  • 财政年份:
    2018
  • 资助金额:
    $ 19.41万
  • 项目类别:
Arizona Neurological Emergencies Treatment Trials Network
亚利桑那州神经紧急情况治疗试验网络
  • 批准号:
    7417535
  • 财政年份:
    2007
  • 资助金额:
    $ 19.41万
  • 项目类别:
Arizona Neurological Emergencies Treatment Trials Network
亚利桑那州神经紧急情况治疗试验网络
  • 批准号:
    7631220
  • 财政年份:
    2007
  • 资助金额:
    $ 19.41万
  • 项目类别:
Arizona Neurological Emergencies Treatment Trials Network
亚利桑那州神经紧急情况治疗试验网络
  • 批准号:
    7256116
  • 财政年份:
    2007
  • 资助金额:
    $ 19.41万
  • 项目类别:
Arizona Neurological Emergencies Treatment Trials Network
亚利桑那州神经紧急情况治疗试验网络
  • 批准号:
    7807901
  • 财政年份:
    2007
  • 资助金额:
    $ 19.41万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 19.41万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了